Combining drug-disease and economic modelling to inform drug development decisions.

Combining drug-disease and economic modelling to inform drug development decisions.

Item
http://www.wikidata.org/entity/Q34432186
Removing obstacles in neuroscience drug discovery: the future path for animal models.Contribution of economic evaluation to decision making in early phases of product development: a methodological and empirical review.Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients.Integrated Simulation Framework for Toxicity, Dose Intensity, Disease Progression, and Cost Effectiveness for Castration-Resistant Prostate Cancer Treatment With EribulinThe use of clinical utility assessments in early clinical developmentBenefit-risk assessment: the use of clinical utility index.The current role of model-based drug development.Mechanism-based approach to the economic evaluation of pharmaceuticals: pharmacokinetic/pharmacodynamic/pharmacoeconomic analysis of rituximab for follicular lymphoma.The use of a clinical utility index to compare insomnia compounds: a quantitative basis for benefit-risk assessment.Clinical trials simulation: a statistical approach.
P2860

Combining drug-disease and economic modelling to inform drug development decisions.

Item
http://www.wikidata.org/entity/Q34432186
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Combining drug-disease and economic modelling to inform drug development decisions.
@ast
Combining drug-disease and economic modelling to inform drug development decisions.
@en
Combining drug-disease and economic modelling to inform drug development decisions.
@nl
type
label
Combining drug-disease and economic modelling to inform drug development decisions.
@ast
Combining drug-disease and economic modelling to inform drug development decisions.
@en
Combining drug-disease and economic modelling to inform drug development decisions.
@nl
prefLabel
Combining drug-disease and economic modelling to inform drug development decisions.
@ast
Combining drug-disease and economic modelling to inform drug development decisions.
@en
Combining drug-disease and economic modelling to inform drug development decisions.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Combining drug-disease and economic modelling to inform drug development decisions.
@en
P2093
P304
P31
P356
10.1016/S1359-6446(01)02014-1
P433
P478
P577
P698